A Focus on Allergic Asthma, for Pulmonologists eBook
Focus on Allergic Asthma for Pulmonologists.indd
Dec 16, 2021
Focus on Allergic Asthma for Pulmonologists.indd
Oct 26, 2021
A systematic review of 24 real-world observational studies in adult patients with severe allergic...
Oct 26, 2021
Exacerbation rates and forced expiration volume (FEV1) improvements with omalizumab treatment were...
Oct 25, 2021
The anti-immunoglobulin (IgE) monoclonal antibody omalizumab proved beneficial for all patients...
Oct 5, 2021
The data on biological therapies on Airway remodeling (AR) in severe asthma require further...
Oct 5, 2021
Clinical trials and observational studies have demonstrated that omalizumab is safe and effective...
Oct 5, 2021
This review summarizes research on mast cells, and the implications of the role and development of mast cells in allergic asthma. The study focuses on the progenitors of mast cells in allergic asthma as well as selected...
Oct 5, 2021
With monoclonal antibodies being a relatively new therapy option for patients with severe chronic airway diseases, asthma, allergic rhinitis, and chronic rhinosinusitis (CRS), researchers completed a review of the physiological...
Oct 5, 2021
Although data support the successful use of omalizumab as a supplementary therapy to improve asthma control in children older than 6 with moderate or severe persistent allergic asthma, the effectiveness of this agent in children...